Start Over

De Novo Lower Urinary Tract Symptoms in COVID-19 Patients.

Authors :: Jain S
Kothari A
Pipal DK
Rani V
Yadav S
Tomar V
Kumar M
Bhargava A
Usmani A
Soni A
Source :: Cureus [Cureus] 2023 Jan 18; Vol. 15 (1), pp. e33947. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Publication Year :: 2023
Abstract: Background and objective Since early 2020, the novel coronavirus disease 2019 (COVID-19) has turned into a global healthcare concern. The usual clinical presentation of COVID-19 infection includes myalgia, headache associated with pyrexia, and sore throat. Our study aimed to assess the severity of lower urinary tract symptoms (LUTS) in COVID-19 patients and determine its correlation with the prognosis of the disease. Methods We conducted an observational study in the COVID-19 care unit at a tertiary care teaching center in Rajasthan on patients diagnosed as COVID-19-positive. The overactive bladder (OAB) symptom scoring system for LUTS and the CT scoring system for lung involvement in COVID-19 patients were used to evaluate the sample population. Results While our findings showed a non-significant association between OAB and CT score (p>0.05), correlation analysis revealed that the length of hospital stay was significantly longer and oxygen needs were significantly more frequent with severe LUTS. Conclusions Based on our findings, de novo LUTS, particularly storage symptoms, may be present in COVID-19-positive cases, and the severity of these symptoms may have an impact on the patient's length of stay in the hospital. Hence, doctors and other medical professionals should consider COVID-19-related bladder dysfunctions such as de novo LUTS as part of COVID-19 symptomatology.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2023, Jain et al.)